Acute otitis media (AOM) is an acute inflammatory infection of the middle ear characterized by acute symptoms, middle-ear effusion, and tympanic membrane (TM) inflammation. In urgent care, the highest-yield intervention is often diagnostic accuracy: erythema alone, particularly during crying or fever, does not establish AOM. A bulging TM and objective evidence of middle-ear effusion are more specific findings and should drive antibiotic decisions.[1,2]

Clinical overview and significance

AOM commonly follows a viral upper respiratory infection that produces eustachian tube dysfunction, negative middle-ear pressure, retained fluid, and subsequent inflammation with or without bacterial superinfection. Frequent bacterial pathogens include Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis; respiratory viruses also contribute substantially.[1] Most uncomplicated cases in otherwise healthy children resolve without invasive complications, but pain control, clear follow-up, and timely escalation for complications are essential.

The strongest evidence base and most detailed U.S. recommendations apply to children aged 6 months through 12 years with uncomplicated AOM. Management of AOM in adults is less well studied and is largely extrapolated from pediatric data; adults with a convincing diagnosis are generally treated initially with antibiotics and should be assessed for unusual, recurrent, or persistent disease.[3]

Etiology and risk factors

• Recent viral upper respiratory infection, nasal congestion, or seasonal respiratory-virus exposure.
• Young age, especially 6 to 24 months; group child care; lack of breastfeeding; tobacco-smoke exposure; craniofacial anomalies; and impaired eustachian tube function.
• Prior AOM, recent antibiotic exposure, and local antimicrobial-resistance patterns.
• Immunocompromise, cochlear implant, cleft palate, tympanostomy tubes, and significant craniofacial abnormalities. These patients may fall outside routine uncomplicated-AOM pathways and warrant a lower threshold for specialist input or emergency evaluation.

Typical clinical presentation

Children may have otalgia, ear tugging, irritability, sleep disruption, fever, decreased oral intake, or otorrhea. Older children and adults more often report pressure, reduced hearing, and focal ear pain. Symptoms are nonspecific; otalgia may originate from the external canal, teeth, temporomandibular joint, pharynx, or cervical structures. AOM may coexist with conjunctivitis, which raises the likelihood of beta-lactamase-producing H. influenzae and influences antibiotic selection.[1,2]

Focused history

• Onset, severity, laterality, otorrhea, hearing change, fever, vomiting, hydration, and behavioral change.
• Duration of otalgia; severe AOM includes moderate-to-severe otalgia, otalgia for 48 hours or longer, or temperature at least 39°C (102.2°F).[1]
• Recent amoxicillin or other antibiotic exposure, especially within the preceding 30 days; prior treatment failure; recurrent episodes; drug allergy phenotype; and prior culture results.
• Recent swimming, ear instrumentation, trauma, tympanostomy tubes, chronic perforation, or hearing-device use.
• Diabetes, immunocompromise, renal or hepatic disease, pregnancy, anticoagulation, medication interactions, and ability to obtain follow-up.
• For adults: unilateral persistent effusion, recurrent AOM, tobacco exposure, nasal obstruction, weight loss, dysphagia, neck mass, dental pain, or temporomandibular symptoms. Persistent unilateral middle-ear disease requires evaluation beyond repeated empiric treatment.

Focused examination and diagnostic approach

Document vital signs, general appearance, hydration, mental status, and pain severity. Inspect the pinna, mastoid, auricle position, external canal, and surrounding skin before otoscopy. Remove obstructing cerumen only when it can be done safely by a trained clinician with appropriate visualization and equipment; do not cause canal trauma or delay emergency transfer in an unstable patient.

Use the largest comfortable speculum and obtain an unobstructed view of the entire TM. Assess color, translucency, landmarks, position, mobility, perforation, and otorrhea. Pneumatic otoscopy is preferred for identifying effusion; tympanometry may support the presence of effusion when the examination is uncertain but does not replace visualization of the TM.[1-3]

For children, diagnose AOM when one of the following is present:

• Moderate or severe TM bulging.
• New-onset otorrhea not explained by acute otitis externa.
• Mild TM bulging plus recent onset of otalgia within 48 hours or intense TM erythema.

Do not diagnose AOM without evidence of middle-ear effusion. A retracted or neutral TM with air-fluid level, visible bubbles, amber fluid, or reduced mobility but without acute inflammatory findings is more consistent with otitis media with effusion (OME), for which systemic antibiotics are not indicated.[1,2]

Point-of-care testing and imaging

Routine laboratory testing, ear cultures, viral testing, and imaging are not indicated for uncomplicated AOM. Tympanocentesis is not a routine urgent-care procedure; it is generally reserved for severe illness, repeated treatment failure, immunocompromise, suspected resistant infection, or a need for microbiologic diagnosis, usually in consultation with otolaryngology.[1] Obtain CT or MRI only when a complication is suspected and in coordination with emergency or specialty care; imaging should not delay transfer.

Differential diagnosis

• OME: effusion without acute inflammatory symptoms or a bulging TM.
• Acute otitis externa: canal edema/debris, pain with tragal pressure or pinna movement, often with a normal TM if visible.
• TM perforation from AOM: acute purulent otorrhea, often after pain suddenly improves.
• Viral myringitis or bullous myringitis: painful TM inflammation; evaluate for middle-ear effusion rather than assuming isolated external-ear disease.
• Referred otalgia: pharyngitis, dental infection, temporomandibular disorder, cervical pathology, and, in adults, head and neck malignancy.
• Cholesteatoma or chronic suppurative otitis media: chronic or recurrent foul-smelling drainage, retraction pocket, keratin debris, or progressive hearing loss; arrange otolaryngology evaluation.
• Necrotizing otitis externa: severe persistent otalgia, granulation tissue, cranial neuropathy, diabetes, or immunocompromise; this is not routine AOM.

Must-not-miss diagnoses and emergency transfer criteria

Transfer to an emergency department, preferably by emergency medical services when clinically unstable, for toxic appearance, altered mental status, meningismus, seizure, focal neurologic deficit, severe dehydration, inability to maintain oral intake, sepsis concern, or airway compromise. Urgently transfer or obtain same-day emergency/specialist assessment for suspected mastoiditis: postauricular erythema, swelling, fluctuance, marked tenderness, or inferolateral displacement of the pinna.[5]

Other red flags include facial weakness, new vertigo, nystagmus, severe headache, diplopia, orbital symptoms, persistent severe pain despite treatment, cranial neuropathy, or concern for intracranial extension. New vertigo or facial weakness with otorrhea/perforation may indicate an intratemporal complication and warrants urgent imaging-capable evaluation.[6] Infants younger than 6 months, febrile neonates, and patients with cochlear implants, significant immune compromise, or severe craniofacial anomalies need individualized management and generally should not be managed with a standard observation pathway.

Management

Analgesia for every patient

Analgesia is foundational whether antibiotics are prescribed or observation is selected. Use medication reconciliation to avoid duplicate acetaminophen-containing products and assess contraindications before recommending an NSAID.

• Acetaminophen: adults commonly receive 325 to 1,000 mg orally every 4 to 6 hours as needed; do not exceed the applicable product, patient-specific, or institutional daily maximum. Pediatric dosing is typically 10 to 15 mg/kg orally every 4 to 6 hours as needed; use the child’s current weight and do not exceed 75 mg/kg/day or 4,000 mg/day, whichever is lower, unless a more restrictive local policy applies. Use lower limits or avoid excess dosing in substantial hepatic impairment, chronic heavy alcohol use, malnutrition, or other hepatotoxic exposure.
• Ibuprofen: adults commonly receive 200 to 400 mg orally every 6 to 8 hours as needed, with food if tolerated. Pediatric dosing is typically 10 mg/kg orally every 6 to 8 hours as needed, maximum 40 mg/kg/day; do not exceed usual adult single-dose limits. Avoid or use cautiously with dehydration, kidney disease, active gastrointestinal bleeding or ulcer disease, anticoagulation, uncontrolled heart failure, NSAID hypersensitivity, and late pregnancy. Avoid ibuprofen in infants younger than 6 months unless specifically directed by an appropriate clinician. Do not give aspirin to children or adolescents with viral illness because of Reye syndrome risk.[3,7]

Topical anesthetic ear drops may provide brief relief in selected patients with an intact TM, but evidence is limited. Avoid topical anesthetic preparations when perforation or tympanostomy tubes are present unless product labeling and specialist guidance support use.[3]

Observation versus immediate antibiotics in children

For children with a certain diagnosis of uncomplicated AOM, prescribe immediate antibiotics for otorrhea, severe signs or symptoms, bilateral AOM in children 6 through 23 months, or when reliable follow-up cannot be ensured. Observation with analgesia and a defined reassessment plan may be appropriate after shared decision-making for nonsevere unilateral AOM in children 6 through 23 months and for nonsevere unilateral or bilateral AOM in children 2 years or older.[1,2]

Observation means active management, not dismissal: provide pain-control instructions and a mechanism for follow-up or a delayed prescription to begin if symptoms worsen at any time or do not improve within 48 to 72 hours. In high-income settings, antibiotics provide limited early pain benefit for many children and increase adverse effects; benefit is greater with bilateral AOM in children younger than 2 years and with otorrhea.[4]

Antibiotic options for uncomplicated pediatric AOM

Verify weight, formulation concentration, renal function when relevant, allergy history, local formulary limits, and current guidance before prescribing. The doses below are commonly used guideline-based regimens for otherwise healthy children; they are not a substitute for independent dose verification.

• First line—amoxicillin: 80 to 90 mg/kg/day orally divided every 12 hours; use an institutionally approved maximum dose. Select when antibiotics are indicated and the child has not received amoxicillin in the preceding 30 days, has no purulent conjunctivitis, and has no history suggesting amoxicillin-unresponsive recurrent AOM.[1,2] Typical duration is 10 days for children younger than 2 years or with severe symptoms; 7 days for ages 2 to 5 years with mild-to-moderate illness; and 5 to 7 days for children 6 years and older with mild-to-moderate illness.[1]
• Amoxicillin-clavulanate: 90 mg/kg/day of the amoxicillin component plus 6.4 mg/kg/day clavulanate orally in two divided doses, preferably using a high-amoxicillin/low-clavulanate formulation and an institutionally approved maximum. Consider initially after amoxicillin exposure within 30 days, concurrent purulent conjunctivitis, or prior amoxicillin nonresponse; use after initial amoxicillin treatment failure when examination confirms persistent AOM.[1,2] Give with food to reduce gastrointestinal intolerance. Avoid in patients with prior amoxicillin-clavulanate-associated cholestatic jaundice/hepatic dysfunction; adjust for significant renal impairment.
• Nonsevere, non–type I penicillin allergy: options include cefdinir 14 mg/kg/day orally in one or two doses, cefuroxime 30 mg/kg/day orally divided every 12 hours, or cefpodoxime 10 mg/kg/day orally divided every 12 hours, using current labeled and local maximum doses.[1] Clarify the reaction: a nonspecific childhood rash is not equivalent to anaphylaxis, angioedema, respiratory compromise, or severe cutaneous adverse reaction. Cephalosporin selection should be individualized for patients with immediate or severe beta-lactam reactions.
• Failure of appropriate oral therapy or inability to take oral medication: ceftriaxone 50 mg/kg intramuscularly or intravenously once daily for 1 or 3 days is a guideline-listed option; persistent symptoms after initial therapy often require a 3-day course and reassessment.[1] This should not be used reflexively for uncomplicated disease. Confirm allergy history, evaluate bilirubin-related cautions in neonates, and follow local protocols for dilution, administration, observation, and maximum dose.

Avoid routine prophylactic antibiotics for recurrent AOM.[2] Macrolide and clindamycin regimens have important limitations in pathogen coverage and resistance; use them only when a severe beta-lactam allergy or culture-directed indication justifies the tradeoff, guided by current local recommendations or infectious-disease/otolaryngology consultation.

Adults, pregnancy, and complex patients

For adults with a definite diagnosis, common outpatient treatment is amoxicillin 875 mg orally every 12 hours or 500 mg orally every 8 hours; duration is often 5 to 7 days in uncomplicated disease, but adult-specific evidence is limited and local guidance varies.[3,8] Amoxicillin-clavulanate may be appropriate when beta-lactamase coverage is needed, after recent amoxicillin exposure, or with treatment failure; a common adult regimen is 875/125 mg orally every 12 hours for 5 to 7 days. Do not use the 875-mg amoxicillin-clavulanate tablet when estimated glomerular filtration rate is below 30 mL/min; select an adjusted formulation and interval according to current labeling.[9]

In pregnancy, amoxicillin and amoxicillin-clavulanate are commonly used when an antibiotic is clinically indicated, but treatment should account for gestational age, allergy history, renal/hepatic function, and obstetric context. Avoid assuming that pregnancy requires antibiotics for otherwise observation-eligible mild pediatric-style disease; adult AOM management is distinct and should be individualized. In older adults, assess renal function, anticoagulants, frailty, diabetes, immune status, medication interactions, and the possibility of referred otalgia or malignancy rather than repeatedly treating uncertain otoscopic findings.

Reassessment, disposition, and follow-up

Outpatient management is appropriate when the patient is well appearing, has no complication red flags, can hydrate and take oral medication if needed, and has reliable follow-up. Reassess within 48 to 72 hours for worsening symptoms or lack of improvement. At reassessment, confirm the diagnosis; consider concurrent viral illness, otitis externa, nonadherence, incorrect dose or formulation, resistant organisms, and complications before changing antibiotics.[1]

Routine test-of-cure otoscopy is not necessary after clear clinical improvement. Middle-ear effusion can persist after symptoms resolve and does not itself indicate antibiotic failure. Persistent hearing concerns, language delay, developmental vulnerability, recurrent AOM, chronic otorrhea, or effusion persisting for approximately 3 months warrants primary-care and/or otolaryngology follow-up with hearing assessment as appropriate.[1,3]

Return and emergency precautions

• Return urgently for worsening pain, persistent fever, vomiting, dehydration, lethargy, severe headache, neck stiffness, confusion, new hearing decline, new vertigo, facial asymmetry, or rash/drug reaction.
• Seek emergency care for swelling, redness, or tenderness behind the ear; the ear pushed outward or downward; toxic appearance; seizure; altered mental status; or inability to maintain hydration.
• For delayed prescribing, start the antibiotic only according to the documented plan if symptoms worsen at any time or do not improve by 48 to 72 hours, and arrange reassessment when uncertainty exists.

Documentation considerations

• Symptoms, duration, fever, pain severity, otorrhea, laterality, hydration, general appearance, and relevant comorbidities.
• Otoscopic findings for each ear: canal status, cerumen obstruction if present, TM position/bulging, color, mobility/effusion assessment, perforation, tubes, and source of drainage.
• Diagnostic certainty and rationale differentiating AOM from OME or otitis externa.
• Severity classification, observation versus antibiotic shared decision-making, selected regimen, verified weight-based dose and maximum, allergy phenotype, renal/hepatic considerations, and local resistance considerations.
• Analgesia plan, follow-up mechanism, return precautions, and emergency-transfer rationale when applicable.

Clinical takeaways

• Diagnose AOM from acute symptoms plus effusion and TM inflammation—not erythema alone.
• Provide effective analgesia to every patient.
• Use observation selectively only when illness is nonsevere and follow-up is reliable.
• When antibiotics are indicated for children, high-dose amoxicillin is usually first line; use amoxicillin-clavulanate for recent amoxicillin exposure, purulent conjunctivitis, or likely beta-lactamase coverage.
• Persistent or worsening illness requires diagnostic reassessment, not automatic escalation alone.
• Postauricular swelling, auricular displacement, neurologic findings, facial weakness, vertigo, systemic toxicity, or dehydration require emergency-level evaluation.

References

1. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3):e964-e999. doi:10.1542/peds.2012-3488.
2. Centers for Disease Control and Prevention. Outpatient clinical care for pediatric populations: acute otitis media. Atlanta (GA): CDC; 2024.
3. Gaddey HL, Wright MT, Nelson TN. Otitis media: rapid evidence review. Am Fam Physician. 2019;100(6):350-356.
4. Venekamp RP, Sanders SL, Glasziou PP, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2023;11:CD000219. doi:10.1002/14651858.CD000219.pub5.
5. Jan TA, Lustig LR. Mastoiditis. Merck Manual Professional Edition. Revised January 2024.
6. MSD Manual Professional Edition. Otorrhea. Rahway (NJ): Merck Sharp & Dohme LLC; 2026.
7. Centers for Disease Control and Prevention. Sore throat basics. Atlanta (GA): CDC; 2024.
8. DailyMed. Amoxicillin capsule: prescribing information. Bethesda (MD): National Library of Medicine; 2025.
9. DailyMed. Amoxicillin and clavulanate potassium: prescribing information. Bethesda (MD): National Library of Medicine; 2025.

Educational disclaimer: This UrgentWiki article is for clinician education and does not replace independent clinical judgment, local antimicrobial-susceptibility data, current drug labeling, institutional protocols, specialist consultation, or patient-specific assessment. Independently verify all medication doses, maximum doses, contraindications, interactions, pregnancy considerations, renal/hepatic adjustments, and current guidelines before clinical use.

Primary keyword: cerumen removal urgent care

Clinical overview

Cerumen is a normal mixture of glandular secretions and desquamated epithelium in the external auditory canal. It lubricates and acidifies the canal and contributes to its protective barrier. Cerumen should not be removed simply because it is visible. Cerumen impaction is present when cerumen causes symptoms or prevents an indicated assessment of the ear canal, tympanic membrane (TM), or audiovestibular system; complete canal occlusion is not required.[1,2]

Common reasons for cerumen removal in urgent care include conductive hearing reduction, fullness, itching, tinnitus, discomfort, hearing-aid malfunction, or inability to assess a patient with otalgia, fever, otorrhea, suspected otitis media, trauma, or a foreign body. Effective approaches include cerumenolytic therapy, irrigation, and manual removal under direct visualization. Current evidence does not establish that one technique is universally superior; method selection should be individualized to cerumen consistency, anatomy, TM status, patient cooperation, clinician skill, and equipment availability.[1-4]

Cerumen removal urgent care visits are usually low acuity, but the procedure can cause canal trauma, bleeding, infection, vertigo, TM perforation, and delayed recognition of another diagnosis. The safest clinician is not necessarily the clinician who removes all wax at the first encounter; it is the clinician who recognizes when not to proceed and arranges appropriate follow-up or referral.

Clinical significance, etiology, and risk factors

Cerumen ordinarily migrates laterally through epithelial migration and jaw movement. Impaction occurs when this clearance mechanism is impaired or when material is pushed medially. Cotton-tipped swabs, earbud devices, hairpins, and other objects commonly worsen impaction and may abrade the canal or injure the TM.[1,2]

• Older adults: drier, harder cerumen; increased canal hair; hearing-aid use; cognitive impairment; and difficulty reporting symptoms.
• Pediatric patients: narrow canals, limited cooperation, and difficulty communicating hearing loss, pain, or dizziness.
• Hearing aids, earplugs, and in-ear devices: may impede normal extrusion and promote accumulation.
• Anatomic factors: canal stenosis, exostoses, osteoma, scar tissue, or postsurgical anatomy.
• Behavioral factors: repetitive self-cleaning or insertion of objects into the canal.
• Patients unable to report symptoms: dementia, developmental disability, nonverbal status, or severe illness. Cerumen may merit removal when it blocks needed examination, even when symptoms cannot be reliably elicited.[1,2]

Typical presentation and focused history

Symptoms potentially attributable to impaction include unilateral or bilateral decreased hearing, a blocked sensation, itching, tinnitus, mild otalgia, hearing-aid feedback, cough, or occasional imbalance. Pain that is substantial, progressive, nocturnal, or disproportionate to the examination should not automatically be attributed to wax.[1,2]

Focused history checklist

• Onset and laterality of hearing change; sudden versus gradual course.
• Otalgia, otorrhea, bleeding, fever, pruritus, vertigo, tinnitus, nausea, facial weakness, headache, or mastoid pain.
• Recent swimming, diving, air travel, barotrauma, trauma, foreign-body insertion, or attempts at home removal.
• Prior TM perforation, tympanostomy tubes, mastoid surgery, tympanoplasty, myringoplasty, canal-wall-down mastoidectomy, or other ear surgery.
• History of recurrent otitis externa, chronic otorrhea, cholesteatoma, dermatologic canal disease, radiation to the head or neck, or known canal abnormalities.
• Diabetes, immunocompromise, anticoagulant or antiplatelet therapy, bleeding disorder, and medication allergies.
• Ability to cooperate and remain still; need for caregiver assistance, restraint policy review, or referral.

Ask specifically whether the patient has experienced pain when water enters the ear or has had prior instructions to avoid water in the ear. Either history should raise concern for a nonintact TM and makes routine irrigation inappropriate.[1,5]

Focused examination and diagnostic approach

Document vital signs when symptoms suggest infection or systemic illness. Inspect the auricle, tragus, pinna, periauricular skin, and mastoid before otoscopy. Tragal or pinna tenderness, canal edema, purulent debris, granulation tissue, vesicles, mastoid tenderness, auricular displacement, or cranial nerve abnormalities require assessment beyond uncomplicated cerumen impaction.

Perform otoscopy before deciding on a removal technique. Note laterality; degree of obstruction; cerumen consistency; canal edema, erythema, trauma, narrowing, or discharge; whether any TM is visible; and whether a foreign body, insect, keratin debris, mass, or cholesteatoma is possible. If the TM can be seen, document its appearance and integrity.

When clinically relevant and feasible, perform a baseline bedside hearing screen such as whispered voice, finger rub, or formal audiometry available in the clinic. A normal hearing screen does not exclude pathology. Persistent hearing loss after adequate wax clearance requires reassessment rather than attribution to residual wax.[2,5]

Differential diagnosis and must-not-miss conditions

• Otitis externa: canal edema, pain with tragal/pinna movement, discharge, or debris may be obscured by cerumen.
• Acute otitis media, TM perforation, or chronic suppurative ear disease: especially with pain, fever, discharge, or a history of perforation/tubes.
• Foreign body or insect: do not assume all obstructing material is cerumen.
• Keratosis obturans or external canal cholesteatoma: may present with obstructive keratin, pain, canal widening, recurrent difficult “wax,” or bony erosion; specialist assessment is appropriate.
• Sudden sensorineural hearing loss: abrupt hearing loss, particularly unilateral loss with tinnitus or vertigo, is an otologic emergency and should not be delayed by repeated wax-removal attempts.
• Malignant (necrotizing) otitis externa: consider in patients with diabetes or immunocompromise who have severe persistent otalgia, otorrhea, granulation tissue, cranial neuropathy, or systemic illness.
• Mastoiditis, Ramsay Hunt syndrome, stroke, or central neurologic disease: consider when mastoid findings, vesicles, facial palsy, focal deficits, severe headache, or central vertigo features are present.

Red flags requiring emergency department transfer or emergent specialty-directed evaluation

• Acute neurologic deficit, facial weakness, altered mental status, severe headache, or inability to ambulate safely.
• Severe vertigo with neurologic symptoms, persistent vomiting, or concern for central cause.
• Sudden or rapidly progressive hearing loss not clearly explained by obstructing cerumen.
• Postprocedural severe pain, brisk or persistent bleeding, acute marked hearing decline, severe tinnitus, or vertigo suggesting TM or middle-ear injury.
• Suspected mastoiditis, invasive otitis externa, severe infection in an immunocompromised patient, or systemic toxicity.
• Penetrating ear trauma, suspected skull fracture, or cerebrospinal fluid leak.

Urgent outpatient ENT referral is generally more appropriate than emergency transfer for stable patients with difficult impaction, prior complex ear surgery, suspected perforation without acute instability, canal stenosis/exostoses, recurrent failed removal, or a patient who cannot safely cooperate with office treatment.

Management principles

Treat symptomatic impaction or wax that prevents a necessary examination. Observation is appropriate for asymptomatic, nonobstructive cerumen. Before starting, identify modifying factors: suspected or known nonintact TM, prior ear surgery, canal stenosis or exostoses, diabetes, immunocompromise, anticoagulant therapy, bleeding disorder, prior head-and-neck radiation, dermatologic canal disease, and inability to remain still.[1,2]

The three accepted intervention categories are cerumenolytics, irrigation, and manual removal. A staged approach is often safest: soften when appropriate, remove with the least traumatic technique available, stop if pain or injury occurs, and refer rather than escalating force or repeated instrumentation.[1,4,5]

Cerumenolytic options

Cerumenolytics may soften or loosen wax before irrigation or manual removal and may be used as a short course when immediate removal is unnecessary. Systematic-review evidence suggests ear drops may be more effective than no treatment, but evidence is limited and does not reliably identify a superior active ingredient.[3] Water- or saline-based preparations, mineral oil, sodium bicarbonate preparations, hydrogen peroxide preparations, docusate products, and carbamide peroxide products are used in practice. Product selection should follow local formulary, labeling, allergy history, and clinician judgment.

Carbamide peroxide 6.5% otic solution

• Indication: short-term aid to soften, loosen, and remove excessive cerumen.
• Typical labeled dosing for adults and children older than 12 years: 5 to 10 drops into the affected ear, otic route, twice daily for up to 4 days. The head remains tilted for several minutes; any remaining wax may subsequently be gently flushed with warm water when clinically appropriate.[6]
• Pediatrics: the referenced over-the-counter label directs consultation with a clinician for children younger than 12 years. Do not extrapolate adult drop volumes or duration to younger children without independently verifying the selected product labeling and local pediatric guidance.[6]
• Do not use routinely when: ear drainage, significant ear pain, canal rash/irritation, dizziness, known or suspected TM perforation, recent ear surgery, or allergy to a component is present, unless specifically directed by an appropriate clinician.[6]
• Counseling: use in the ear only; do not insert the dropper tip into the canal; transient bubbling or crackling may occur; stop and seek reassessment for pain, rash, dizziness, drainage, or persistent obstruction.

There is no role for systemic antibiotics, oral analgesics solely for routine wax removal, or prophylactic otic antibiotics after an uncomplicated procedure. If canal trauma, otitis externa, TM injury, or another diagnosis is identified, management should be diagnosis-specific. Independently verify current medication labeling, pediatric dosing, allergy risks, pregnancy/lactation information, renal/hepatic considerations, drug interactions, and local treatment guidance before prescribing or recommending any medication. Renal and hepatic dose adjustment is generally not a central issue for locally administered cerumenolytics, but this does not eliminate the need to review the individual product label and the patient’s complete medication and allergy profile.

Pregnancy is not, by itself, an indication for or contraindication to cerumen removal. Prefer nonpharmacologic removal when safe and clinically indicated, use the least necessary exposure, and verify the specific product label or obstetric/pharmacy guidance before recommending a cerumenolytic during pregnancy or lactation.

Procedure: ear irrigation

Indications

Irrigation is reasonable for symptomatic or examination-limiting cerumen that is soft or has been appropriately softened, when the patient is cooperative and there is no concern for a nonintact TM or other contraindication.

Do not perform routine irrigation when

• TM perforation, tympanostomy tube, otorrhea, uncertain TM healing after tube placement, or suspected nonintact TM.
• History of mastoid surgery, tympanoplasty, myringoplasty, or other surgery that alters ear anatomy unless the managing specialist has specifically cleared irrigation.
• Current otitis externa, significant canal inflammation, foreign body requiring another technique, or suspected cholesteatoma/keratosis obturans.
• Canal stenosis, exostoses, severe distortion, or anatomic conditions likely to retain water.
• Patient cannot remain adequately still or communicate distress safely.
• Clinician lacks direct visualization, appropriate equipment, training, or a safe escalation/referral plan.

Diabetes, immunocompromise, anticoagulation, bleeding disorders, and prior radiation are modifying risk factors rather than automatic prohibitions. However, they should lower the threshold for a gentle alternative technique, early referral, and careful postprocedure reassessment.[1,2,5]

Preparation, consent, and equipment

• Otoscope with appropriately sized specula and adequate lighting.
• Body-temperature or near-body-temperature water or saline; cold or hot fluid can provoke vestibular symptoms.
• Purpose-designed low-pressure irrigation system or syringe with soft catheter/tubing; collection basin; absorbent drape/towel; gloves; and cerumenolytic when appropriate.
• Manual-removal instruments and/or suction only if the clinician is trained and can maintain direct visualization.

Explain expected transient fullness, noise, and mild discomfort. Discuss risks including pain, dizziness, canal abrasion, bleeding, infection, incomplete removal, and rare TM injury. Obtain and document verbal informed consent according to clinic policy. Local anesthetic drops are not routinely useful for cerumen removal; injection into the canal is painful and is not a standard approach.[5]

Step-by-step irrigation technique

1. Confirm indication, laterality, relevant history, and absence of contraindications. Perform and document preprocedure otoscopy.
2. Position the patient seated or semireclined with the head supported. Place a basin snugly below the ear. Instruct the patient to keep the head still and to report pain, vertigo, or sudden hearing change immediately.
3. If appropriate, instill a cerumenolytic and allow adequate dwell time. In a time-limited urgent care visit, a same-visit dwell period may be used; dense, dry impaction may be better managed with a home-softening course and scheduled reattempt or referral.
4. Gently straighten the canal: pull the pinna up and back in adults and generally down and back in young children.
5. Place the soft irrigation tip only at the canal entrance, without advancing deeply. Direct a moderate, controlled stream along the superior or posterior canal wall and around the wax, not directly at the TM. Avoid excessive pressure.[5]
6. Pause frequently to inspect for wax movement, pain, bleeding, canal injury, or intolerance. Do not persist through pain or repeated failed attempts.
7. Stop immediately for severe pain, vertigo, tinnitus, bleeding, sudden hearing change, suspected perforation, or patient movement that compromises safety.
8. After clearance, dry the external ear gently and re-examine the canal and TM. Do not leave the visit without confirming outcome, retained wax, or injury status.

Do not use high-pressure dental water-jet devices or improvised high-pressure systems. Excess pressure can injure the TM.[5]

Procedure: manual removal and suction

Manual removal with a curette, loop, hook, forceps, or suction may be preferred when irrigation is contraindicated, when wax is focal and visible, or when water retention is undesirable. It requires a cooperative patient, appropriate illumination, direct visualization, and clinician competency. Manual removal can be faster, but blind probing is unsafe.[2,5]

Technique essentials

1. Use an otoscope designed for procedures or equivalent visualization that permits the instrument to remain visible.
2. Stabilize the patient’s head. For children or patients with limited cooperation, use trained assistance and follow institutional policies; do not force a procedure that cannot be safely completed.
3. Select the instrument based on wax consistency: a curette or loop for accessible soft-to-firm wax; forceps for graspable fragments; suction for soft fragments when the equipment and expertise are available.
4. Engage only the lateral, visible edge of wax and withdraw it outward. Avoid advancing an instrument beyond what can be continuously visualized.
5. Stop for pain, bleeding, inability to visualize, worsening impaction, sudden movement, or concern for TM proximity. Refer rather than continuing repeated attempts.
6. Re-examine and document the canal and TM after the procedure.

Routine urgent care should not attempt manual removal of deeply impacted wax abutting an unseen TM, cerumen in a surgically altered ear, suspected keratin disorder, or impaction in a highly uncooperative patient who may require sedation or specialized equipment. ENT referral is appropriate in these circumstances.[1,5]

Post-procedure reassessment, complications, and aftercare

After any attempted removal, document whether the canal is clear, partially clear, or still obstructed; whether the TM is visualized and intact; and whether the original symptom improved. Reassess hearing when it was a presenting concern. If symptoms persist despite an adequately clear canal and normal TM examination, broaden the differential diagnosis and arrange appropriate follow-up.[1,2,5]

Potential complications include pain, canal abrasion or laceration, bleeding, retained fluid, otitis externa, vasovagal symptoms, vertigo, tinnitus, TM perforation, and failure to remove wax. Postprocedure topical antimicrobials are not routine after uncomplicated cerumen removal. If trauma or infection is suspected, avoid potentially ototoxic agents when TM integrity is uncertain and use diagnosis-specific treatment or specialty consultation after independently verifying current drug guidance.

Aftercare and return precautions

• Keep the ear dry and avoid inserting swabs, fingers, earbuds, or other objects into the canal until symptoms resolve.
• Return promptly for increasing pain, drainage, fever, rash, persistent or worsening hearing loss, dizziness, tinnitus, bleeding, or recurrent blockage.
• Seek emergency care for severe vertigo, new facial weakness, neurologic symptoms, severe headache, inability to walk safely, or abrupt hearing loss.
• For incomplete but uncomplicated removal, consider a limited course of an appropriate softening agent followed by a planned recheck, or refer to ENT/audiology/ear-care service according to local resources and clinician expertise.

Disposition and follow-up

Discharge from urgent care is appropriate when impaction is resolved or safely deferred, the patient is clinically stable, no red flags are present, and clear follow-up instructions are provided.

Routine or expedited ENT referral is appropriate for repeated unsuccessful attempts; unusual anatomy; prior ear surgery; suspected TM perforation; recurrent difficult impaction; chronic otorrhea; suspected cholesteatoma, keratosis obturans, or canal lesion; significant anticoagulation-related bleeding; need for microsuction or microscopy not available in clinic; or inability to safely cooperate.

Emergency transfer is indicated for the red-flag conditions listed above, particularly acute neurologic findings, severe postprocedural symptoms suggesting injury, suspected invasive infection, mastoiditis, or sudden sensorineural hearing loss.

Documentation considerations

Thorough documentation supports continuity, coding integrity, and risk management. Record the clinical indication rather than documenting only “ear lavage.” Include:

• Laterality and symptoms; duration; hearing impact; and why removal was medically necessary.
• Relevant negatives and positives: otorrhea, pain, fever, dizziness, prior perforation/tubes/surgery, diabetes, immunocompromise, anticoagulants, allergies, and patient cooperation.
• Preprocedure otoscopic findings: degree of obstruction, wax consistency, canal condition, visible TM status, and concern for alternate diagnosis.
• Consent discussion, risks reviewed, patient questions, and verbal consent per policy.
• Method used: cerumenolytic agent and dwell time if used; irrigant type and temperature; low-pressure device/syringe; manual instruments; suction; number of attempts; and which ear or ears were treated.
• Procedure tolerance, complications, reason for stopping if incomplete, and interventions taken.
• Postprocedure findings: residual cerumen, canal trauma or bleeding, TM visualization and condition, change in symptoms/hearing, and follow-up or referral plan.

A concise example: “Right cerumen impaction causing muffled hearing and preventing TM examination. Denies otorrhea, prior TM perforation, tubes, ear surgery, or water intolerance. Preprocedure otoscopy: dry obstructive cerumen; no canal edema or drainage; TM not visualized. Verbal consent obtained after discussion of discomfort, dizziness, canal trauma, bleeding, incomplete removal, and TM injury. Cerumen softened with [agent] for [time], then removed with low-pressure body-temperature saline irrigation. Patient tolerated procedure without pain, vertigo, bleeding, or tinnitus. Postprocedure: canal clear, no abrasion; TM fully visualized and intact. Hearing subjectively improved. Advised against cotton swabs and given return precautions.”

Clinical takeaways

• Remove cerumen when it is symptomatic or blocks a necessary examination; leave asymptomatic, nonobstructive cerumen alone.
• Screen for nonintact TM, prior ear surgery, infection, canal abnormalities, diabetes, immunocompromise, anticoagulation, and ability to cooperate before choosing a method.
• Do not irrigate when TM integrity is uncertain or when there is otorrhea, current canal infection, altered anatomy, or a relevant surgical history.
• Use body-temperature fluid, controlled low pressure, direct visualization, and a low threshold to stop.
• Manual removal is not “safer” when performed blindly or beyond the clinician’s equipment and skill level.
• Always re-examine the canal and TM after an attempt, reassess the presenting complaint, document the procedure in detail, and refer when removal cannot be completed safely.

References

1. Schwartz SR, Magit AE, Rosenfeld RM, Ballachanda BB, Hackell JM, Krouse HJ, et al. Clinical practice guideline (update): earwax (cerumen impaction). Otolaryngol Head Neck Surg. 2017;156(1 Suppl):S1-S29. doi:10.1177/0194599816671491.
2. Michaudet C, Malaty J. Cerumen impaction: diagnosis and management. Am Fam Physician. 2018;98(8):525-529.
3. Aaron K, Cooper TE, Warner L, Burton MJ. Ear drops for the removal of ear wax. Cochrane Database Syst Rev. 2018;7(7):CD012171. doi:10.1002/14651858.CD012171.pub2.
4. National Institute for Health and Care Excellence. Hearing loss in adults: assessment and management. NICE guideline NG98. Recommendations on earwax removal. London: NICE; 2018.
5. Dinces EA. How to remove cerumen manually and with irrigation. Merck Manual Professional Edition. Updated May 2026.
6. DailyMed. Carbamide peroxide 6.5% earwax removal kit solution/drops: drug label information. Bethesda (MD): National Library of Medicine; updated October 28, 2025.

Educational disclaimer: This article is intended for clinician education and does not replace patient-specific assessment, clinical judgment, local protocols, supervision requirements, product labeling, or current specialty guidance. Clinicians should independently verify procedure competency requirements, medication dosing, contraindications, and current guidelines before clinical use.

Sore throat is a high-volume urgent care complaint with a broad differential: most cases are self-limited viral pharyngitis, but a small subset represent group A streptococcal (GAS) pharyngitis, influenza, COVID-19, infectious mononucleosis, sexually transmitted infection, or a potentially life-threatening upper-airway or deep-neck infection. A reliable sore throat urgent care evaluation begins with airway assessment and illness severity—not with a strep test.

Clinical overview

Acute pharyngitis is usually viral. GAS is the most common bacterial cause, accounting for an estimated 20% to 30% of pharyngitis episodes in children and 5% to 15% in adults. Clinical findings alone are insufficient to distinguish GAS from viral pharyngitis when viral features are absent; targeted microbiologic testing is therefore central to antimicrobial stewardship.^[1]

The urgent care clinician must separate patients appropriate for outpatient symptomatic care from those with dehydration, impending airway compromise, sepsis, peritonsillar abscess, retropharyngeal/parapharyngeal infection, epiglottitis, Ludwig angina, or other conditions requiring emergency department (ED) transfer and specialty support.

Etiology and clinical significance

Common viral causes include rhinovirus, adenovirus, seasonal coronaviruses, influenza, SARS-CoV-2, enteroviruses, and Epstein-Barr virus (EBV). GAS typically causes abrupt sore throat, odynophagia, fever, tender anterior cervical adenopathy, palatal petechiae, and tonsillar erythema or exudate. Cough, rhinorrhea, hoarseness, conjunctivitis, and oral ulcers favor a viral syndrome.^[1]

Although rare in routine outpatient practice, clinicians should maintain situational awareness for diphtheria in an undervaccinated patient or a patient with relevant travel or exposure history. A pharyngeal pseudomembrane that may extend into the larynx or trachea is a classic respiratory diphtheria finding and may threaten the airway.^[2]

Focused history

• Timeline and severity: abrupt versus gradual onset; days of illness; progression; unilateral versus bilateral pain; fever; ability to swallow liquids and medications; urine output; and pain severity.
• Airway symptoms: drooling, muffled voice, trismus, stridor, dyspnea, orthopnea, inability to handle secretions, neck swelling, neck stiffness, or pain with neck movement.
• Associated symptoms: cough, coryza, hoarseness, conjunctivitis, oral ulcers, rash, headache, abdominal pain, nausea, vomiting, fatigue, posterior cervical lymphadenopathy, hepatosplenomegaly symptoms, or lower-respiratory symptoms.
• Exposure and epidemiology: household GAS contact; school/daycare or congregate-setting exposure; respiratory-virus activity; known influenza or COVID-19 exposure; travel; vaccination status; and foodborne or outbreak context.
• Sexual history when relevant: oral sexual exposure, known sexually transmitted infection (STI) contact, genital symptoms, and HIV exposure risk. Pharyngeal gonorrhea is often asymptomatic but may cause pharyngeal symptoms and should be considered when exposure history supports testing.^[3]
• Host factors: age; pregnancy; immune suppression; diabetes; cancer therapy; transplant history; HIV; recurrent tonsillitis; recent antibiotics; medication allergies and reaction phenotype; renal or hepatic disease; anticoagulants; and alcohol use.

Focused examination

Begin with appearance and vital signs. Document temperature, heart rate, blood pressure, respiratory rate, oxygen saturation, hydration status, mental status, and whether the patient can speak in full sentences and manage oral secretions.

• Inspect the lips, oral cavity, tongue, floor of mouth, palate, tonsils, posterior pharynx, and buccal mucosa. Note erythema, exudate, ulceration, petechiae, vesicles, thrush, asymmetry, swelling, uvular deviation, bleeding, or pseudomembrane.
• Assess voice quality, trismus, tongue elevation, submandibular induration, drooling, and cervical range of motion.
• Palpate anterior and posterior cervical nodes and evaluate for focal neck mass, fluctuance, or tenderness.
• Examine for scarlatiniform rash, hand/foot lesions, conjunctivitis, hepatosplenomegaly when clinically appropriate, pulmonary findings, and signs of systemic illness.

A careful oropharyngeal examination must not delay emergency transfer in a patient with stridor, respiratory distress, drooling, tripod positioning, severe agitation, altered mental status, or other evidence of a threatened airway. Avoid forceful tongue-depressor examination of a patient with suspected epiglottitis or marked airway compromise.

Differential diagnosis

• Viral pharyngitis: usually associated with cough, rhinorrhea, hoarseness, oral ulcers, conjunctivitis, or diffuse upper-respiratory symptoms.
• GAS pharyngitis/scarlet fever: abrupt sore throat, fever, tender anterior nodes, palatal petechiae, exudative tonsillitis, and sometimes a sandpaper-like rash.
• EBV infectious mononucleosis: marked fatigue, posterior cervical adenopathy, diffuse adenopathy, tonsillar exudate, and possible splenomegaly or transaminitis.
• Influenza and COVID-19: pharyngitis may accompany fever, myalgia, cough, headache, malaise, or lower-respiratory symptoms.
• Peritonsillar cellulitis or abscess: unilateral severe pain, “hot potato” voice, uvular displacement, trismus, drooling, and referred otalgia.
• Retropharyngeal or parapharyngeal infection: toxic appearance, neck pain or stiffness, muffled voice, limited neck extension, dysphagia, or respiratory symptoms; young children may present nonspecifically.
• Odontogenic infection/Ludwig angina: dental source, floor-of-mouth swelling, tongue elevation, submandibular induration, or inability to manage secretions.
• STI-associated pharyngitis: gonorrhea, acute HIV, and, less commonly, syphilis or herpes simplex virus, depending on syndrome and exposure.
• Noninfectious causes: allergic/postnasal irritation, reflux, smoke or chemical irritation, medication-related mucositis, aphthous disease, malignancy, and foreign body or trauma.

Must-not-miss diagnoses and red flags

Arrange immediate ED transfer, preferably by emergency medical services when airway risk is present, for:

• Stridor, respiratory distress, cyanosis, hypoxia, tripod positioning, inability to speak comfortably, or rapidly progressive symptoms.
• Drooling, inability to swallow liquids or secretions, clinically important dehydration, or inability to take oral medication.
• Trismus, muffled voice, uvular deviation, substantial unilateral tonsillar/soft-palate swelling, or concern for peritonsillar abscess.
• Neck swelling, floor-of-mouth elevation, submandibular induration, torticollis, significant neck stiffness, or pain with neck extension.
• Toxic appearance, persistent tachycardia/hypotension, altered mental status, concern for sepsis, or immunocompromise with severe illness.
• Suspected epiglottitis, deep-neck-space infection, Lemierre syndrome, or diphtheria.

Peritonsillar abscess may progress to airway obstruction, aspiration, extension into deep neck spaces, mediastinitis, or vascular complications. Airway assessment and stabilization take priority over imaging or attempted drainage.^[4,5]

Diagnostic approach

When GAS testing is useful

Do not routinely test for GAS when the presentation has clear viral features such as cough, rhinorrhea, hoarseness, oral ulcers, or conjunctivitis. In patients without clear viral features, use a validated clinical prediction tool, such as a Centor or McIsaac-based approach, to estimate pretest probability and guide testing rather than relying on clinical appearance alone. The 2025 IDSA guideline update supports use of clinical scoring systems to identify patients at sufficiently low probability of GAS who may not require testing.^[1,6]

GAS pharyngitis is uncommon in children younger than 3 years; routine testing is generally not indicated unless there are special epidemiologic considerations, such as a symptomatic child with a close household GAS contact.^[1]

Rapid antigen detection tests, molecular assays, and culture

• Rapid antigen detection test (RADT): A positive RADT is highly specific and confirms GAS. Sensitivity varies compared with culture.
• Throat culture: Remains the reference standard. For symptomatic children age 3 years and older, obtain a backup throat culture after a negative RADT and maintain a reliable process to notify the family and start treatment if culture is positive.
• Adults and other ages: Backup culture after a negative RADT is not routinely indicated because acute rheumatic fever is very rare in these groups.
• Molecular/NAAT testing: Follow the assay’s instructions for use and local laboratory policy. High-sensitivity molecular tests may reduce the need for reflex culture, but workflows vary by platform and local protocol.

Collect a high-quality throat specimen by vigorously swabbing both tonsillar pillars and the posterior pharynx while avoiding the tongue and cheeks when possible. Inadequate sampling is a common cause of false-negative results.

Testing beyond GAS

Test for SARS-CoV-2 and influenza when results will alter treatment, infection-control decisions, or disposition—particularly in patients at elevated risk for severe disease. When available, multiplex molecular assays can detect SARS-CoV-2 and influenza together. A negative SARS-CoV-2 antigen test does not reliably exclude infection in a symptomatic patient; repeat antigen testing or nucleic acid testing should follow current regulatory and local guidance.^[7,8]

For suspected EBV, heterophile antibody testing may be used in an appropriate clinical syndrome, but it has important false-positive and false-negative limitations, especially in children. CDC does not recommend the Monospot test for general use. Consider EBV-specific serology when the presentation is atypical or when diagnostic clarification will change management. CBC and hepatic tests may be useful when illness is significant, prolonged, or complicated, but should not be routine for every sore throat.^[9]

Obtain pharyngeal gonorrhea nucleic acid amplification testing when exposure history indicates. If pharyngeal gonorrhea is diagnosed, CDC recommends a test of cure 7 to 14 days after treatment because eradication is more difficult at the pharyngeal site.^[3]

Imaging is not routine for uncomplicated pharyngitis. In a stable patient with concern for deep-neck infection or diagnostic uncertainty, ED-based contrast-enhanced CT and/or specialist-directed ultrasound may be appropriate. Do not delay airway management or transfer to obtain outpatient imaging.

Management

Uncomplicated viral pharyngitis

Provide supportive care: oral hydration, warm or cold liquids according to patient preference, salt-water gargles for patients able to gargle safely, rest, and analgesic/antipyretic therapy. Explain that antibiotics do not treat viral pharyngitis and create risks of adverse drug reactions, Clostridioides difficile infection, and antimicrobial resistance.

Analgesic and antipyretic options

• Acetaminophen: For adults, a typical dose is 650 to 1,000 mg orally every 6 hours as needed. Do not exceed 4,000 mg/day from all sources in adults and adolescents age 12 years and older; use a lower individualized ceiling in patients with hepatic impairment, substantial alcohol use, frailty, malnutrition, or clinician-directed restrictions. Pediatric dosing is weight-based; verify the product concentration, dosing interval, and maximum daily dose before use. Counsel patients to check combination cold/flu products for acetaminophen/APAP.^[10]
• Ibuprofen: For adults without contraindications, a typical analgesic dose is 200 to 400 mg orally every 6 to 8 hours as needed; prescription regimens and maximum daily doses vary. Pediatric dosing is weight-based and should include a maximum dose. Avoid or use cautiously in chronic kidney disease, dehydration, active gastrointestinal bleeding or ulcer disease, anticoagulant use, uncontrolled hypertension, heart failure, and NSAID hypersensitivity. Avoid routine NSAID use in pregnancy at 20 weeks’ gestation or later unless specifically directed; avoid after approximately 30 weeks because of fetal risk.^[11]

Topical anesthetic lozenges or sprays may offer short-term relief in selected patients, but product-specific age restrictions, aspiration risk, allergy history, and toxicity precautions matter. Avoid recommending oral benzocaine products to very young children because of safety concerns and follow current product labeling.

Corticosteroids

A single corticosteroid dose may modestly improve the likelihood of symptom resolution at 48 hours, but guideline support is weak and shared decision-making is appropriate. It should not substitute for airway evaluation, drainage, or antibiotics when those are indicated. A commonly studied adult regimen is dexamethasone 10 mg orally or intramuscularly once; pediatric regimens are weight-based, often dexamethasone 0.6 mg/kg once to a maximum of 10 mg. Avoid routine use in suspected infectious mononucleosis, immunocompromised patients without a clear indication, recurrent sore throat, poorly controlled diabetes, or when masking progression of a deep infection is a concern. Verify local protocols and current dosing before use.^[12]

Confirmed GAS pharyngitis

Treat patients with a positive RADT or throat culture. Penicillin and amoxicillin remain preferred because clinical GAS isolates have not been reported resistant to penicillin or cephalosporins. Macrolide and clindamycin resistance occurs and varies geographically and over time; use local antibiograms and public-health information when selecting these agents.^[1]

• Penicillin V: Adults and adolescents: 500 mg orally twice daily for 10 days, or 250 mg orally four times daily for 10 days. Children: 250 mg orally two or three times daily for 10 days.
• Amoxicillin: 50 mg/kg orally once daily, maximum 1,000 mg/day, for 10 days; alternatively, 25 mg/kg orally twice daily, maximum 500 mg per dose, for 10 days.
• Benzathine penicillin G: Single intramuscular dose when adherence to a 10-day oral regimen is doubtful: 600,000 units for weight below 27 kg; 1.2 million units for weight 27 kg or greater.

For a non-immediate penicillin allergy, cephalexin 20 mg/kg/dose orally twice daily (maximum 500 mg/dose) for 10 days is an option. Do not use cephalexin or cefadroxil in patients with immediate-type penicillin hypersensitivity. Alternative regimens include clindamycin 7 mg/kg/dose orally three times daily (maximum 300 mg/dose) for 10 days, azithromycin 12 mg/kg once (maximum 500 mg), then 6 mg/kg once daily (maximum 250 mg) for 4 days, or clarithromycin 7.5 mg/kg/dose twice daily (maximum 250 mg/dose) for 10 days.^[1]

Before prescribing, document the allergy phenotype rather than using “penicillin allergy” as an undifferentiated label. Review renal function for renally eliminated antibiotics and adjust when indicated; assess hepatic disease and interaction risks for macrolides. Macrolides may prolong QT interval and have clinically important CYP-mediated interactions. Clindamycin has a meaningful risk of antibiotic-associated diarrhea and C. difficile infection. In pregnancy, penicillin-class agents are commonly used when indicated, but antibiotic selection should be individualized using current labeling, allergy history, gestational age, and obstetric considerations.

For confirmed GAS, advise patients to remain home from school, work, or daycare until afebrile and at least 12 to 24 hours after starting appropriate antibiotics.^[1]

Special populations

• Pediatrics: Children are more vulnerable to dehydration and may have nonspecific presentations of serious deep-neck infection. Use weight in kilograms, verify liquid concentrations, document maximum doses, and arrange backup culture after a negative RADT in symptomatic children age 3 years and older.
• Pregnancy: Evaluate respiratory-virus treatment eligibility promptly because time-sensitive antivirals may be relevant. Avoid casual NSAID recommendations; medication choice should account for gestational age and obstetric comorbidity.
• Older adults: Do not dismiss severe symptoms because fever may be absent. Assess medication interactions, renal reserve, anticoagulation, aspiration risk, and atypical presentations of sepsis.
• Immunocompromised patients: Lower the threshold for ED evaluation, expanded testing, imaging, and specialist consultation when symptoms are severe, progressive, persistent, or associated with oral lesions or systemic findings.

Disposition, follow-up, and return precautions

Outpatient management is reasonable when the patient has a stable airway, can tolerate oral fluids and medication, has reassuring vital signs and examination, and has reliable follow-up. Arrange follow-up for persistent symptoms, uncertain diagnosis, pending throat culture, positive STI testing, suspected EBV with activity counseling needs, or any patient at increased risk of complications.

Advise immediate emergency evaluation for breathing difficulty, noisy breathing, drooling, inability to swallow liquids, worsening unilateral swelling, trismus, muffled voice, neck swelling or stiffness, confusion, fainting, persistent vomiting, reduced urine output, or clinical deterioration. Patients with suspected EBV should avoid contact sports and activities with abdominal trauma risk until clinically recovered and cleared as appropriate because splenic enlargement can occur.^[13]

Documentation considerations

• Document airway assessment, secretion handling, hydration status, vital signs, and absence or presence of red flags.
• Record clinical prediction score elements when used, GAS test type/result, specimen collection plan, reflex culture plan, and communication method for pending results.
• Describe asymmetry, uvular position, trismus, voice quality, neck examination, and rationale for ED transfer or outpatient care.
• For antibiotics, document indication, allergy phenotype, renal/hepatic considerations, counseling, shared decision-making when relevant, and local resistance considerations for macrolide or clindamycin use.

Clinical takeaways

• Airway and hydration assessment come before strep testing.
• Clear viral symptoms usually eliminate the need for GAS testing.
• Positive RADT confirms GAS; negative RADT in symptomatic children age 3 years and older requires backup throat culture.
• Do not treat a negative GAS test or presumed viral pharyngitis with antibiotics.
• Unilateral swelling, trismus, muffled voice, drooling, neck symptoms, or respiratory compromise should trigger urgent escalation rather than routine outpatient treatment.
• Verify all medication doses, formulations, contraindications, interactions, renal/hepatic adjustments, pregnancy considerations, test instructions for use, and current national/local guidance independently before clinical application.

References

1. Centers for Disease Control and Prevention. Clinical guidance for group A streptococcal pharyngitis [Internet]. Atlanta (GA): CDC; 2025 Nov 18 [cited 2026 Aug 18].
2. Centers for Disease Control and Prevention. Clinical features of diphtheria [Internet]. Atlanta (GA): CDC; 2025 May 12 [cited 2026 Aug 18].
3. Centers for Disease Control and Prevention. Gonococcal infections among adolescents and adults. In: Sexually transmitted infections treatment guidelines, 2021 [Internet]. Atlanta (GA): CDC; 2021 [cited 2026 Aug 18].
4. Akhavan M. Ear, nose, throat: beyond pharyngitis: retropharyngeal abscess, peritonsillar abscess, epiglottitis, bacterial tracheitis, and postoperative tonsillectomy. Emerg Med Clin North Am. 2021;39(3):541-556. doi:10.1016/j.emc.2021.04.012.
5. Krishnaprasadh D, Hohman MH, McDowell RH. Peritonsillar abscess. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan 31 [cited 2026 Aug 18].
6. Barshak MB, Linder JA, Watson ME Jr, Wessels MR, Carter DM, Cohen AL, et al. 2025 clinical practice guideline update by the Infectious Diseases Society of America on group A streptococcal pharyngitis: risk assessment using clinical scoring systems in children and adults. Clin Infect Dis. 2025. doi:10.1093/cid/ciaf310.
7. Centers for Disease Control and Prevention. Clinical guidance for hospitalized and non-hospitalized patients when SARS-CoV-2, RSV, and influenza viruses are co-circulating [Internet]. Atlanta (GA): CDC; 2026 May 4 [cited 2026 Aug 18].
8. Centers for Disease Control and Prevention. Testing for COVID-19 [Internet]. Atlanta (GA): CDC; 2025 Mar 10 [cited 2026 Aug 18].
9. Centers for Disease Control and Prevention. Laboratory testing for Epstein-Barr virus (EBV) [Internet]. Atlanta (GA): CDC; 2024 Apr 10 [cited 2026 Aug 18].
10. US Food and Drug Administration. Acetaminophen [Internet]. Silver Spring (MD): FDA; 2026 [cited 2026 Aug 18].
11. US Food and Drug Administration. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid [Internet]. Silver Spring (MD): FDA; 2020 Oct 15 [updated 2022 Sep 1; cited 2026 Aug 18].
12. Aertgeerts B, Agoritsas T, Siemieniuk RAC, Burgers J, Ekkering GE, Merglen A, et al. Corticosteroids for sore throat: a clinical practice guideline. BMJ. 2017;358:j4090. doi:10.1136/bmj.j4090.
13. Centers for Disease Control and Prevention. About infectious mononucleosis (mono) [Internet]. Atlanta (GA): CDC; 2024 May 9 [cited 2026 Aug 18].

Educational disclaimer: This article is intended for clinician education and does not replace individualized assessment, local protocols, specialist consultation, medication labeling, or current guideline review. Medication dosing and treatment decisions must be independently verified before clinical use.

Why ENT complaints require disciplined examination

ENT symptoms account for a large share of urgent-care visits. Most are uncomplicated and self-limited, but their familiarity creates a risk: the clinician may stop reasoning after recognizing a common symptom pattern. “Ear infection” may actually be otitis externa, middle-ear effusion, referred dental pain, temporomandibular disease, mastoiditis, or sudden sensorineural hearing loss. “Sore throat” may be viral pharyngitis, group A streptococcal infection, peritonsillar abscess, retropharyngeal infection, epiglottitis, or an evolving airway emergency.

The urgent-care task is not simply to select an antibiotic. It is to localize the affected structure, determine whether the disease is uncomplicated or invasive, identify threats to airway, vision, hearing, neurologic function, or circulation, and choose a safe disposition.

Start with airway and physiologic stability

Before focusing on an ear or throat, assess general appearance and obtain a complete set of vital signs. Observe whether the patient can speak normally, manage secretions, drink, and breathe comfortably. Do not force an agitated child with suspected upper-airway obstruction into a position that worsens distress.

Emergency evaluation is generally indicated for:

• Stridor, respiratory distress, cyanosis, tripod positioning, drooling with inability to swallow, rapidly progressive voice change, or suspected epiglottitis
• Expanding floor-of-mouth or neck swelling, tongue elevation, trismus with toxicity, or concern for Ludwig angina or deep-neck infection
• Unilateral pharyngeal swelling with airway symptoms, severe dehydration, sepsis, or extension beyond a straightforward peritonsillar process
• Neck stiffness or swelling, torticollis, toxic appearance, or neurologic symptoms concerning for retropharyngeal or parapharyngeal infection
• Sudden facial weakness, focal neurologic deficit, severe headache, meningismus, altered mental status, or intracranial complication
• Proptosis, ophthalmoplegia, pain with eye movement, reduced vision, afferent pupillary defect, or severe orbital symptoms
• Postauricular swelling or erythema with auricular displacement, systemic illness, or suspected mastoiditis
• Sudden hearing loss that may be sensorineural, particularly with neurologic findings
• Uncontrolled epistaxis, hemodynamic instability, major blood loss, airway compromise, or posterior bleeding
• Button battery in the nose or ear, penetrating trauma, caustic exposure, or airway foreign body
• Severe otalgia in a patient with diabetes or immunocompromise when invasive external-ear infection is possible

Normal oxygen saturation does not exclude a threatened upper airway. Likewise, absence of fever does not exclude a serious infection in an older or immunocompromised patient.

Localize the complaint before naming the disease

ENT evaluation becomes more reliable when the clinician asks which anatomic compartment is involved.

• External ear: Auricle, tragus, canal, and surrounding soft tissue
• Middle ear: Tympanic membrane and air-containing middle-ear cleft
• Inner ear or auditory nerve: Cochlear and vestibular structures; sensorineural function
• Nose and sinuses: Anterior nasal cavity, septum, turbinates, and paranasal sinuses
• Oropharynx: Tonsils, soft palate, uvula, posterior pharynx, and tongue base
• Deep neck: Peritonsillar, retropharyngeal, parapharyngeal, and submandibular spaces
• Referred sources: Teeth, temporomandibular joint, cervical spine, salivary glands, larynx, and head or neck tumors

A symptom label should never substitute for direct visualization when visualization is feasible and safe.

Focused history

Onset and trajectory

Determine whether symptoms began suddenly or gradually and whether they are improving, stable, or rapidly worsening. Sudden hearing change over hours is different from chronic cerumen-related fullness. “Sinus pressure” for three days is different from persistent symptoms beyond ten days or improvement followed by a second deterioration.

Ear-specific questions

Ask about laterality, hearing change, tinnitus, vertigo, drainage, water exposure, instrumentation, trauma, air travel, recent upper-respiratory infection, previous perforation, tubes, surgery, hearing devices, and severe nocturnal pain. Clarify whether pain is triggered by chewing or jaw movement. Diabetes and immunocompromise increase concern for invasive infection.

Nose and sinus questions

Ask about obstruction, discharge, facial pain or pressure, smell change, fever, dental pain, allergy symptoms, epistaxis, trauma, intranasal medication or drug use, anticoagulants, and recurrent unilateral symptoms. Determine duration and whether there was “double worsening” after initial improvement.

Throat and neck questions

Ask about cough, rhinorrhea, hoarseness, conjunctivitis, oral ulcers, fever, odynophagia, dysphagia, drooling, voice change, trismus, neck pain or stiffness, unilateral symptoms, rash, sexual exposure, recent antibiotics, immunization status, and contact with group A streptococcal infection. Clarify whether the patient can swallow liquids and secretions.

Host and medication factors

Review age, pregnancy, allergies and their reaction phenotype, renal or hepatic disease, diabetes, immune status, anticoagulant or antiplatelet use, tobacco and alcohol exposure, prior resistant organisms, recurrent infections, recent hospitalization, and previous ENT procedures.

Focused examination

General and airway examination

Record appearance, work of breathing, voice, secretion control, hydration, and ability to open the mouth. Inspect and palpate the neck for swelling, tenderness, asymmetry, fluctuance, crepitus, lymphadenopathy, and range of motion. Do not aggressively depress the tongue or examine the throat in a way that delays airway management when epiglottitis is suspected.

Ear examination

Inspect the auricle, mastoid, tragus, and canal before viewing the tympanic membrane. Document canal edema, erythema, debris, discharge, foreign body, vesicles, and tenderness with tragal pressure or auricular manipulation.

For the tympanic membrane, document:

• Degree of bulging or retraction
• Opacity, translucency, and landmarks
• Perforation or tube status
• Effusion and air-fluid level when visible
• Mobility with pneumatic otoscopy when available and appropriate
• Otorrhea and its likely source

A tympanic membrane can appear erythematous from crying, fever, or canal irritation. In children, the AAP recommends diagnosing acute otitis media when there is moderate-to-severe tympanic-membrane bulging or new otorrhea not caused by otitis externa; mild bulging requires recent otalgia or intense erythema. Middle-ear effusion should be present.[1]

When hearing loss is reported, perform and document a basic hearing assessment. A whispered voice or finger rub can screen gross asymmetry. Weber and Rinne testing can help distinguish conductive from sensorineural loss, but imperfect technique or equivocal results should not create false reassurance.

Nasal and sinus examination

Inspect the anterior septum, mucosa, turbinates, discharge, visible bleeding site, foreign body, and septal swelling. Bilateral boggy or pale turbinates may support allergic rhinitis, but color alone is not diagnostic. Facial tenderness is nonspecific and should not be used alone to diagnose bacterial sinusitis.

After nasal trauma, specifically assess for a septal hematoma: soft, fluctuant, often bilateral septal swelling that can obstruct the airway and does not shrink with topical vasoconstrictor. This requires urgent drainage by a clinician with appropriate expertise because delayed treatment can cause cartilage necrosis and deformity.

Mouth, throat, and neck examination

Use adequate light. Inspect lips, dentition, gingiva, tongue, floor of mouth, buccal mucosa, tonsils, pillars, uvula, soft palate, posterior pharynx, and visible lesions. Note exudate, petechiae, ulcers, asymmetry, palatal bulging, uvular deviation, drooling, muffled voice, trismus, tongue elevation, dental infection, and neck mobility.

The classic “hot-potato” voice or uvular deviation may support peritonsillar abscess, but neither is universally present. A patient with marked trismus, unilateral swelling, toxic appearance, airway concerns, or uncertain anatomy may require imaging, drainage capability, specialty consultation, or emergency transfer.

Ear complaints: pattern-based approach

Acute otitis media

Acute otitis media is an inflammatory middle-ear process with acute symptoms and objective effusion. Bulging—not redness alone—is the central otoscopic finding. Distinguish AOM from otitis media with effusion, in which fluid is present without acute middle-ear inflammation; antibiotics do not treat uncomplicated residual effusion.

Pain control is part of management regardless of whether antibiotics are prescribed. In children, the decision between immediate antibiotics and observation depends on age, diagnostic certainty, severity, otorrhea, laterality, reliable follow-up, and shared decision-making. Severe symptoms include moderate-to-severe otalgia, otalgia for at least 48 hours, or temperature at or above 39°C in the AAP framework.[1]

When antibiotics are indicated, amoxicillin is commonly first-line for appropriate uncomplicated pediatric patients. Recent amoxicillin exposure, purulent conjunctivitis, treatment failure, allergy phenotype, recurrent disease, or complicating factors may change selection. Verify current dosing and duration based on age, weight, severity, renal function, and local guidance.

Expected pain and fever improvement usually begins within 48–72 hours. Persistent or worsening symptoms warrant reassessment of the diagnosis, adherence, drug selection, resistant pathogens, perforation, mastoiditis, or another pain source.

Acute otitis externa

Diffuse acute otitis externa typically causes canal inflammation, otalgia, and tenderness with tragal pressure or pinna movement. Canal edema or debris may prevent full tympanic-membrane visualization. Topical therapy is preferred for uncomplicated diffuse disease; systemic antibiotics are not initial therapy unless infection extends beyond the canal or important host factors alter management. Adequate analgesia is essential.[2]

Select non-ototoxic drops when the tympanic membrane is perforated, a tube is present, or membrane integrity is uncertain. A wick may improve drug delivery through a markedly edematous canal when performed competently. Counsel the patient to keep the ear dry, avoid instrumentation, and administer drops correctly. Reassess nonresponse within 48–72 hours.

Severe deep pain, granulation tissue, cranial neuropathy, or disease in a patient with diabetes or major immune compromise raises concern for necrotizing otitis externa and requires urgent specialty or hospital evaluation.

Cerumen impaction and foreign body

Cerumen is “impacted” when it causes symptoms or prevents a necessary examination—not merely because wax is visible. Before irrigation, consider tympanic-membrane perforation, tubes, prior ear surgery, canal stenosis, active infection, anticoagulation, immunocompromise, and whether the object can swell or cause trauma.

Do not irrigate a button battery, sharp object, or vegetable matter that may expand. Stop after failed or traumatic attempts; repeated instrumentation increases edema, bleeding, perforation risk, and pushes the object deeper. Early referral is appropriate for a tightly wedged object, poor visualization, proximity to the membrane, uncooperative patient, prior failed attempts, or lack of safe equipment.

Sudden hearing loss

Sudden sensorineural hearing loss can be mistaken for cerumen, congestion, or eustachian-tube dysfunction. Ask exactly when the change occurred and whether tinnitus, vertigo, neurologic symptoms, or unilateral fullness accompanied it. Examine the canal and membrane, then use bedside hearing tests when possible to separate conductive from sensorineural loss.

Suspected sudden sensorineural hearing loss requires urgent audiometry and ENT-directed treatment. The AAO-HNS guideline emphasizes prompt differentiation from conductive loss and timely evaluation; corticosteroid therapy may be offered within two weeks of symptom onset, while treatment decisions require individualized contraindication review.[3] Focal neurologic findings, severe headache, or stroke concern require emergency evaluation rather than routine referral.

Nose and sinus complaints

Viral rhinosinusitis versus acute bacterial rhinosinusitis

Most acute nasal and sinus symptoms are viral. Purulent-colored discharge alone does not establish bacterial infection. Clinical patterns supporting acute bacterial rhinosinusitis include:

• Persistent compatible symptoms for at least ten days without improvement
• Severe onset with high fever and purulent discharge or facial pain for several consecutive days
• Worsening symptoms after initial improvement—the “double-sickening” pattern

These patterns are reflected in IDSA guidance.[4] Evaluate orbital and neurologic findings before choosing outpatient care. Antibiotic selection should follow current guidance and incorporate age, allergy, pregnancy, renal function, recent antibiotics, local resistance, and disease severity.

Supportive treatment may include hydration, saline irrigation with properly treated water, analgesics, and intranasal corticosteroid when appropriate, especially with allergic inflammation. Explain that many cases improve without antibiotics and that cough or congestion can persist after the peak illness.

Unilateral foul discharge in a child suggests a nasal foreign body. Persistent unilateral symptoms in an adult should prompt consideration of dental disease, structural obstruction, fungal disease, or neoplasm.

Epistaxis

Initial care begins with positioning the patient upright and leaning forward, clearing large clots when appropriate, and firmly compressing the soft cartilaginous portion of the nose continuously. Pinching the nasal bones or repeatedly releasing pressure is ineffective. Topical vasoconstrictor may help when not contraindicated.

Once bleeding slows, inspect for an anterior source. Treatment may include targeted cautery or packing based on visualization, equipment, clinician skill, anticoagulation, and bleeding severity. Cauterize only the identified site and avoid indiscriminate bilateral septal cautery because of perforation risk. Document packing type, removal plan, medication considerations, and explicit return precautions. AAO-HNS guidance supports structured compression, site identification, appropriate packing, and referral for recurrent or difficult-to-control bleeding.[5]

Recurrent unilateral epistaxis, recurrent bleeding despite prior packing or cautery, suspected posterior bleeding, hereditary hemorrhagic telangiectasia features, anemia, tumor concern, or anticoagulation complexity warrants further evaluation. Do not reflexively stop prescribed anticoagulants without weighing thrombotic risk and coordinating care.

Sore throat and neck complaints

Viral versus group A streptococcal pharyngitis

Viruses cause most pharyngitis. Cough, rhinorrhea, hoarseness, oral ulcers, and conjunctivitis strongly support a viral cause. In the absence of clear viral features, examination alone cannot reliably separate viral from group A streptococcal pharyngitis.[6]

Use a validated clinical decision framework to guide testing rather than prescribing from tonsillar exudate alone. A positive rapid antigen test, nucleic-acid amplification test where used, or culture confirms group A streptococcal infection. For symptomatic children aged three years or older, CDC guidance recommends a backup throat culture after a negative rapid antigen test; routine backup culture is not generally indicated for adults.[6]

Treat confirmed group A streptococcal pharyngitis. Penicillin or amoxicillin remains first-line when appropriate. Clarify whether a reported penicillin allergy was an immediate hypersensitivity reaction, a severe delayed reaction, or an intolerance because this changes alternatives. Macrolide and clindamycin resistance varies geographically, whereas group A streptococcal resistance to penicillin has not been reported.[6]

Antibiotics are not indicated for viral pharyngitis. Provide analgesia, hydration guidance, transmission precautions, and reassessment instructions. A patient treated for uncomplicated pharyngitis who develops worsening unilateral pain, trismus, voice change, neck swelling, or inability to swallow needs reevaluation for a suppurative complication.

Peritonsillar abscess and deep-neck infection

Peritonsillar abscess often presents with progressive unilateral throat pain, muffled voice, trismus, drooling, ipsilateral otalgia, palatal swelling, and possible uvular deviation. Cellulitis can look similar. Drainage plus antimicrobial therapy is generally required for a drainable abscess, but the safest setting depends on airway stability, anatomy, clinician competence, patient cooperation, bleeding risk, hydration, and access to follow-up.

Retropharyngeal or parapharyngeal infection may produce fever, neck stiffness, torticollis, drooling, muffled voice, dysphagia, swelling, or toxicity. Younger children may present nonspecifically. These infections can compromise the airway or spread to the mediastinum, vascular structures, or intracranial space. Arrange emergency imaging, ENT consultation, intravenous therapy, and airway-capable care rather than treating as simple pharyngitis.

Ludwig angina, epiglottitis, and dental sources

Ludwig angina is a rapidly progressive cellulitis of the submandibular and sublingual spaces, commonly arising from dental infection. Floor-of-mouth induration, tongue elevation, drooling, dysphagia, voice change, and neck swelling are ominous. Airway deterioration can be abrupt; prioritize emergency airway-capable transfer and avoid delaying for routine outpatient testing.

Epiglottitis may present with severe throat pain, odynophagia, drooling, muffled voice, stridor, or symptoms disproportionate to routine oropharyngeal findings. Vaccination has changed its epidemiology but has not eliminated it. Keep the patient calm, minimize unnecessary manipulation, and activate emergency airway management.

Dental abscesses and temporomandibular disorders commonly refer pain to the ear or throat. Inspect the teeth and floor of mouth. Antibiotics do not replace definitive dental drainage or extraction when required.

Diagnostic testing: answer a specific question

• Rapid antigen testing, NAAT, or throat culture: Confirms group A streptococcal infection in the appropriate clinical context.
• Pneumatic otoscopy or tympanometry: Supports identification of middle-ear effusion when available and performed correctly.
• Audiometry: Urgently confirms and quantifies suspected sudden sensorineural hearing loss.
• Point-of-care ultrasound: May support assessment of selected superficial abscesses or peritonsillar processes in trained hands, but it does not replace airway judgment.
• CT with contrast: Often required in emergency or hospital settings for suspected deep-neck, orbital, intracranial, complicated sinus, or invasive infectious processes. Transfer should not be delayed when the airway or physiology is threatened.
• CBC, metabolic testing, cultures, or coagulation studies: Reserve for systemic illness, significant bleeding, immune compromise, complications, or results likely to change management.

Avoid shotgun respiratory testing or imaging when results will not alter treatment. Conversely, do not allow a negative rapid test to override an examination suggesting a deep-space or airway emergency.

Medication and procedure safeguards

Antibiotics

State the anatomic diagnosis and why bacterial disease is likely. Verify allergy phenotype, recent antimicrobial use, pregnancy, kidney and liver function, interactions, weight-based pediatric calculations, and local resistance. Provide expected response and a defined failure threshold. Antibiotics do not drain pus, remove a foreign body, correct septal hematoma, or restore hearing from every cause.

Corticosteroids

Corticosteroids may have a defined role in selected conditions, including specialist-directed sudden sensorineural hearing loss, but they should not be used as a nonspecific injection for every sore throat, sinus complaint, or ear symptom. Consider diabetes, infection, pregnancy, psychiatric effects, gastrointestinal risk, immunosuppression, and masking of progression. Steroids do not secure an airway or replace drainage.

Decongestants and topical vasoconstrictors

Review hypertension, cardiovascular disease, pregnancy, glaucoma, urinary retention risk, interactions, and age restrictions. Prolonged use of topical nasal decongestants can cause rebound congestion. Intranasal corticosteroids require correct direction away from the septum and regular use; they do not provide immediate relief like a vasoconstrictor.

Procedures

Procedures such as cerumen removal, ear-wick placement, nasal cautery, packing, foreign-body removal, or peritonsillar drainage require correct equipment, visualization, consent, patient cooperation, and rescue planning. Stop when anatomy is uncertain, bleeding obscures the field, repeated attempts are causing trauma, or the required skill exceeds the setting.

Disposition and follow-up

Discharge is appropriate only when the patient is stable, can maintain hydration and medication, has no threat to airway, vision, hearing, neurologic function, or deep structures, and has realistic follow-up.

Provide condition-specific expectations:

• Viral upper-respiratory and throat symptoms often peak over several days and then gradually improve; cough and congestion may linger.
• AOM pain and fever should generally begin improving within 48–72 hours of appropriate management.
• Otitis externa should show meaningful improvement within 48–72 hours after effective drop delivery.
• Bacterial sinusitis should be reassessed when symptoms worsen or fail to improve within the expected interval after treatment.
• Epistaxis may recur if the mucosa is traumatized or dry; explain pressure technique and packing instructions.

Immediate emergency precautions should include difficulty breathing, stridor, drooling, inability to swallow, rapidly increasing neck or tongue swelling, severe dehydration, confusion, severe headache, stiff neck, facial weakness, eye pain or vision change, postauricular swelling, uncontrolled bleeding, or sudden/worsening hearing loss.

Documentation that demonstrates clinical reasoning

Include:

• Symptom onset, progression, laterality, exposures, associated features, and prior treatment
• Vital signs, appearance, airway status, voice, secretion control, and hydration
• Ear canal, mastoid, tympanic-membrane, hearing, nasal, oral, dental, pharyngeal, and neck findings relevant to the complaint
• Important negatives such as no trismus, drooling, uvular deviation, floor-of-mouth elevation, postauricular swelling, pain with eye movement, neurologic deficit, or respiratory distress—only when actually assessed
• Tests performed and how they changed management
• Working diagnosis and dangerous alternatives considered
• Medication selection, allergy assessment, pediatric weight, and dose verification
• Procedure consent, technique, findings, complications, and aftercare
• Follow-up interval, referral urgency, and specific return precautions

Example medical-decision-making language

Patient is clinically stable, managing secretions, and tolerating oral intake without stridor, respiratory distress, drooling, trismus, muffled voice, uvular deviation, floor-of-mouth swelling, neck rigidity, or toxic appearance. Oropharyngeal findings and testing support uncomplicated pharyngitis at this time. Peritonsillar abscess, deep-neck infection, epiglottitis, and Ludwig angina were considered but are not supported by the current examination. Outpatient management is reasonable with close follow-up and immediate emergency precautions for airway symptoms, inability to swallow, progressive unilateral swelling, voice change, neck stiffness, or clinical deterioration.

Adapt the language to the actual patient. Do not import normal findings that were not examined.

Coding considerations

Common ICD-10-CM examples include:

• H66.90 — Otitis media, unspecified, unspecified ear
• H60.90 — Unspecified otitis externa, unspecified ear
• H61.20 — Impacted cerumen, unspecified ear
• H91.20 — Sudden idiopathic hearing loss, unspecified ear
• J02.9 — Acute pharyngitis, unspecified
• J02.0 — Streptococcal pharyngitis
• J01.90 — Acute sinusitis, unspecified
• R04.0 — Epistaxis
• J36 — Peritonsillar abscess

Use greater specificity for laterality, acuity, recurrence, perforation, organism, complication, and encounter details when supported. Verify the current code set.

Procedure-code families may include removal of impacted cerumen, removal of an ear or nasal foreign body, control of anterior or posterior nasal hemorrhage, and drainage of a peritonsillar abscess. Coding depends on technique, complexity, laterality, anesthesia, separate evaluation-and-management work, bundling rules, and documentation. Do not choose a procedure code merely because an attempt was made; verify the current CPT descriptor and payer policy.

Clinical pearls

• A red tympanic membrane is not synonymous with AOM; look for bulging and effusion.
• Tragal or pinna tenderness localizes disease toward the external canal.
• Ear pain with a normal ear examination should trigger a search for referred pain.
• Treat pain even when observation rather than antibiotics is appropriate.
• Use non-ototoxic ear drops when membrane integrity is uncertain.
• Sudden unilateral hearing loss is time-sensitive until sensorineural loss is excluded.
• Colored nasal discharge alone does not diagnose bacterial sinusitis.
• Do not miss a septal hematoma after nasal trauma.
• Exudate alone cannot distinguish viral from streptococcal pharyngitis.
• A normal-looking anterior throat does not exclude epiglottitis or deep-neck disease.
• Trismus, drooling, voice change, tongue elevation, and neck stiffness are escalation clues.
• Firm pressure on the soft nose—not the nasal bones—is first-line epistaxis care.
• Repeated foreign-body attempts often make the eventual removal harder and riskier.
• When airway or deep-space infection is possible, disposition matters more than a polished outpatient diagnosis.

Conclusion

A safe urgent-care ENT assessment follows a consistent sequence: stabilize the airway and physiology, localize the involved structure, obtain direct visualization when safe, distinguish uncomplicated disease from invasive or function-threatening pathology, and match treatment to the anatomy.

The most important habits are simple but consequential: diagnose AOM by bulging and effusion rather than redness, separate external from middle-ear disease, treat sudden sensorineural hearing loss as time-sensitive, use duration and trajectory to assess sinus symptoms, test selectively for streptococcal pharyngitis, and actively search for deep-neck and airway warnings. When the patient may lose an airway, vision, hearing, neurologic function, or substantial blood volume, timely escalation is the definitive urgent-care intervention.

References

1. Lieberthal AS, Carroll AE, Chonmaitree T, Ganiats TG, Hoberman A, Jackson MA, et al. The diagnosis and management of acute otitis media. Pediatrics. 2013;131(3). doi:10.1542/peds.2012-3488. Available from: https://publications.aap.org/pediatrics/article/131/3/e964/30912/The-Diagnosis-and-Management-of-Acute-Otitis-Media
2. Rosenfeld RM, Schwartz SR, Cannon CR, Roland PS, Simon GR, Kumar KA, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(1 Suppl). doi:10.1177/0194599813517083. Available from: https://www.entnet.org/quality-practice/quality-products/clinical-practice-guidelines/aoe/
3. Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019;161(1 Suppl). doi:10.1177/0194599819859885. Available from: https://www.entnet.org/quality-practice/quality-products/clinical-practice-guidelines/sudden-hearing-loss-update/
4. Chow AW, Benninger MS, Brook I, Brozek JL, Goldstein EJC, Hicks LA, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8). doi:10.1093/cid/cis370. Available from: https://www.idsociety.org/practice-guideline/rhinosinusitis/
5. Tunkel DE, Anne S, Payne SC, Ishman SL, Rosenfeld RM, Abramson PJ, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngol Head Neck Surg. 2020;162(1 Suppl). doi:10.1177/0194599819890327. Available from: https://www.entnet.org/quality-practice/quality-products/clinical-practice-guidelines/nosebleed-epistaxis/
6. Centers for Disease Control and Prevention. Clinical guidance for group A streptococcal pharyngitis [Internet]. Atlanta: CDC; 2025 Nov 18 [cited 2026 Aug 14]. Available from: https://www.cdc.gov/group-a-strep/hcp/clinical-guidance/strep-throat.html